Media Pack
News

Current Edition

IPI Volume 16 Issue 1
 
 
 
 
 
 
Volume 15 Issue 4

IMI Mobilise-D: The Next Generation of Mobility Research

Mobility represents an important marker of health, and a slow walking speed is associated with a greater risk of disease, cognitive decline, risk of falls and even e...
19 December 2023 Volume 15 Issue 4 chronic | cognitive decline
Continue Reading →
Volume 15 Issue 4

Ensuring the World’s Access to Vital Medicine: The Role of the Cargo Industry in Pharmaceutical Transport

During the global pandemic, the importance of transporting vital vaccines and medicines was brought sharply into the spotlight. COVID-19 amplified just how important...
19 December 2023 Volume 15 Issue 4 access | cargo
Continue Reading →
Volume 14 Issue 4

Bad Medicine: Lessons from an Enduring Alliance between Big Pharma and Global Policing

The challenges of tackling international crime with national law enforcement are legion. John Binns, a partner in the Financial Crime team at BCL Solicitors consider...
13 January 2023 Volume 14 Issue 4 consumers | enforcement
Continue Reading →
News

Iconovo receives $883,800 grant from the Bill & Melinda Gates Foundation

Funding will develop inhaled therapies using ICOone Nasal in preparation for the next pandemic. Iconovo has revealed that it has received a grant of $883,800 from...
27 July 2022 News COVID-19 | Foundation
Continue Reading →
Uncategorised

China eliminates import duties on 28 Indian medicines

China has exempted import tariffs (duties) for 28 drugs, including all cancer drugs, from May 1st China has removed import duties on as many as 28 medicines,...
8 May 2018 Uncategorised China | duties
Continue Reading →
News

EMA to review sotagliflozin as potential treatment for type 1 diabetes

The European Medicines Agency (EMA) has accepted for review Sanofi's regulatory submission for sotagliflozin. If approved, the oral treatment would be used as an add...
29 March 2018 News Agency | diabetes
Continue Reading →
What Does the Falsified Medicines Directive (FMD) Mean for SMEs and CMOs; and More Importantly, Are These Organisations Ready?
Volume 9 Issue 4

What Does the Falsified Medicines Directive (FMD) Mean for SMEs and CMOs; and More Importantly, Are These Organisations Ready?

The implications of the directive are far-reaching and affect all pharmaceutical manufacturers, regardless of size. As time runs out and the deadline grows ever clos...
4 January 2018 Volume 9 Issue 4 directive | falsified
Continue Reading →
News

Cardiabase, a Banook Group company, supports the World Health Organization (WHO) in the fight against malaria

Cardiabase, a Banook Group company, the global provider of cardiac safety, central imaging and endpoint adjudication services for clinical trials, today announces th...
29 November 2017 News cardiac safety | cardiotoxicity
Continue Reading →
News

Tjoapack launches new bottle packing line

Contract packaging organisation (CPO), Tjoapack, has launched its new bottle packing line following a major investment earlier this year. The new line, which is now ...
29 November 2017 News bottle | medicines
Continue Reading →
News

At Pharmaceutical Serialization & Traceability Summit 2017, Adents to Address Aspects of Comprehensive Level 4 Solutions

Adents, a leading provider of premier versatile serialization and track-and-trace solutions, will deliver a presentation on November 29 addressing the components nee...
21 November 2017 News compliance | medicines
Continue Reading →
 
 
 
logo-ipi-w.png

International Pharmaceutical Industry

IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative

Facebook Linkedin Tumblr
IPI Media © 2024, All Rights Reserved – Powered by Teksyte